Stocks opened lower on Friday after China said it will slap new tariffs on U.S. goods.US Marketsread more
China said Friday that it will impose new tariffs on $75 billion worth of U.S. goods and resume duties on American autos.Marketsread more
Ideas include a rotation of Federal Reserve governors that would make it easier to curb Powell's power, according to the Washington Post.US Economyread more
The Koch brothers financed one of the most influential political networks in the modern era. The sprawling political empire includes conservative and libertarian nonprofits...Politicsread more
Google on Friday released a new set of community guidelines that are meant to crack down on what employees can say inside the company.Technologyread more
Emails between Facebook employees from 2015 illustrate early actions the company took to investigate third-party use of their data.Technologyread more
Falling air cargo demand could be flashing warning signs about the broader economy.Transportationread more
Moulton was one of the few candidates not to make the debate stages in June and July.2020 Electionsread more
The Fed's James Bullard says the central bank should continue to ease monetary policy because of the recession signal being flashed by the bond market.Investingread more
Here are the biggest calls on Wall Street on FridayInvestingread more
U.S. Secretary of State Mike Pompeo says Huawei CFO Meng Wanzhou, who is under house arrest in Canada and facing extradition to America, is not a bargaining chip in the trade...Technologyread more
Medical marijuana has new competition, and it's fierce: Sales of recreational pot in Colorado are growing faster than sales of medical pot, even though medical marijuana is cheaper because of a lower tax rate.
That trend will continue, according to the most thorough analysis yet of the two, side-by-side legal markets.
GreenWave Advisors, which provides analysis for the cannabis industry, reports that medical marijuana sales growth in Colorado dipped in 2014, as did the number of new medical cardholders.
"We forecast the average patient count will continue to decline from approximately 114,000 in 2014 to 99,000 by 2020," GreenWave said. At the same time, GreenWave predicts that the recreational side will see compound annual growth of 20 percent, "with likely upside as the market expands into new jurisdictions."
Is the future of medical marijuana going up in smoke? GreenWave said current fundamentals indicate that eventually, there will be only one legal marijuana market—one that combines medical and recreational under one set of regulations and a single tax rate.
There's also a chance that medical pot will find ways to differentiate itself from the for-fun kind.
"We believe that the medicinal use market will recalibrate when the pipeline of new, more targeted medications become available and as the medical profession gains more comfort in 'pushing' a marijuana treatment rather than a patient having to 'pull' a prescription," writes GreenWave's Matthew Karnes.
Leslie Bocskor, managing partner of Electrum Partners, an incubator for legal cannabis start-ups, took that prediction about medical pot's future even further last week. He told a group in Las Vegas that one of marijuana's most promising future markets will take cannabis beyond easing problems to curing them. He said there will be markets for pharmaceutical and "nutraceutical" products—meaning supplements and the like. "There will even be a veterinary market," he said.
One problem for those who'd like to see a separate medical marijuana market is that cannabis remains a Class I drug, which means the federal government sees no health benefit to it. Jan Carlos Byl of pot-cultivation consulting firm MedCanna said he would like to see the drug given a less restrictive classification "sooner rather than later, because it opens up research."
Byl said that while many proponents claim there are elements in the cannabis plant that could be very helpful in terms of health, legally recategorizing marijuana "is a key element to being able to definitely, or at least with a higher degree of certainty, say, 'yes or no—this is hogwash or this is legitimate.'"
CORRECTION: This version corrected the description of GreenWave Advisors: It's provides analysis for the cannabis industry.